Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

IMPORTANCE: Despite guideline recommendations, many patients discontinue P2Y(12) inhibitor therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher-potency P2Y(12) inhibitors are underutilized. Cost is frequently cited as an explanation for both of these observations....

Full description

Saved in:
Bibliographic Details
Published in:JAMA
Main Authors: Wang, Tracy Y., Kaltenbach, Lisa A., Cannon, Christopher P., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cohen, David J., Bhandary, Durgesh, Khan, Naeem D., Anstrom, Kevin J., Peterson, Eric D.
Format: Artigo
Language:Inglês
Published: American Medical Association 2019
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583585/
https://ncbi.nlm.nih.gov/pubmed/30620370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.19791
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items